BRIEF-SciClone Q2 non-GAAP earnings per share $0.30

* SciClone Pharmaceuticals Inc - ‍in light of pending merger, company will not be updating its guidance for fiscal 2017​
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.